Mantle cell lymphoma

From Ganfyd

Revision as of 06:31, 23 August 2016 by Mlj (Talk | contribs)
Jump to: navigation, search

Mantle cell lymphoma has a poor long-term prognosis which has improved in the last few decades with now quoted median time to treatment failure of just over 9 years. Long term survival is still problematical.




Chemotherapy is the standard treatment with high-dose cytarabine and immunochemotherapy before autologous stem-cell transplantation being the current standard of treatment in those less than 65 years[1].